Novo Nordisk Shares Surge on New Obesity Drug Results
Market Reaction to Clinical Breakthrough Novo Nordisk shares climbed significantly in early trading Tuesday after the Danish pharmaceutical company announced that its experimental once-weekly weight-loss injection helped clinical trial participants lose an average of 22% of their body weight. The positive data, released at the company’s investor day in Copenhagen, signals a potential shift in…